Skip to content
Study details
Enrolling now

Interventional Radiology and Radiation Therapy for Liver Cancer

Duke University
NCT IDNCT04933435ClinicalTrials.gov data as of Apr 2026
Target enrollment

78

Study length

about 6.3 years

Ages

18+

Locations

2 sites in NC

What this study is about

Researchers are testing how a treatment called Interventional Radiology Liver Directed Therapies or Hypofractionated Image-Guided Radiation Therapy affects the quality of life in people with liver cancer. The trial will measure changes in quality of life from before treatment to one month after treatment.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Quality of life questionnaires

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
All receive treatment

Everyone gets the investigational treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: change in quality of life in patient cohorts receiving either Interventional Radiology Liver Directed Therapies or Hypofractionated Image-Guided Radiation Therapy

Secondary: change in quality of life in patients receiving Interventional Radiology Liver Directed Therapies or HIGRT, number of patients with grade ≥2 acute toxicity that received Hypofractionated Image Guided Radiation Therapy, number of patients with grade ≥2 acute toxicity that received Interventional Liver Directed Therapy, total healthcare system cost associated with Hypofractionated Liver Directed Therapy, total healthcare system cost associated with Interventional Radiology Liver Directed Therapies